Corrigendum to “ Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy Body Disease” [Neurobiology of Disease127 (2019) 163–177]
Brian Spencer,
Ivy Trinh,
Edward Rockenstein,
Michael Mante,
Jazmin Florio,
Anthony Adame,
Omar M.A. El-Agnaf,
Changyoun Kim,
Eliezer Masliah,
Robert A. Rissman
Affiliations
Brian Spencer
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Ivy Trinh
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Edward Rockenstein
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Michael Mante
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Jazmin Florio
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Anthony Adame
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA
Omar M.A. El-Agnaf
Neurological Disorders Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar
Changyoun Kim
Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
Eliezer Masliah
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Laboratory of Neurogenetics National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Division of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA; Corresponding author at: Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.
Robert A. Rissman
Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA; Veterans Affairs San Diego Healthcare System San Diego, CA, USA
